| Adm. | route of administration |
| AP-1 | activator protein-1 transcription factor |
| CAT | catalase |
| COX-2 | cyclooxygenase-2 |
| DOMS | delayed onset muscle soreness |
| Form. | formulation |
| GSH | glutathione |
| H | homeopathic |
| ICAM-1 | intercellular adhesion molecule |
| IFN-γ | interferon gamma |
| IL-12 | interleukin-12 |
| IL-1β | interleukin -1-beta |
| IL-6 | interleukin-6 |
| MCP-1 | monocyte chemoattractant protein-1 |
| MMP1 | collagenase-1 |
| MMP13 | interstitial collagenase-3 |
| NF-kB | transcription factor nuclear factor kappa B |
| O | oral |
| OT | oral transmucosal |
| P | phytotherapeutic |
| ROS | reactive oxygen species |
| SC | subcutaneous |
| SOD | superoxide dismutase |
| STLs | sesquiterpene lactones |
| T | topical |
| TNFα | tumor necrosis factor alpha |
| UHPLC-HRMS | ultra-high-performance liquid chromatography with high-resolution mass spectrometry |
| UV | ultraviolet |